|
⚲
|
| Keyboard |
| Longitude Capital Partners IV LLC | |
|---|---|
| Firm | Longitude Capital Management Co LLC |
| Address | 2740 Sand Hill Road, 2nd Floor Menlo Park, CA 94025 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Longitude Capital Management Co LLC | |||||
| Longitude Venture Partners IV LP | 021-349320 | Executive Officer | of 550.0 M |
1,052.9 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lexeo Therapeutics Inc LXEO
Common Stock
|
2023-11-07 | Conversion | 1,793,429 | ||
|
Lexeo Therapeutics Inc LXEO
Series B convertible preferred stock · derivative
|
2023-11-07 | Conversion | 2,906,148 | ||
|
Lexeo Therapeutics Inc LXEO
Series A convertible preferred stock · derivative
|
2023-11-07 | Conversion | 18,999,999 | ||
|
Lexeo Therapeutics Inc LXEO
Common Stock
|
2023-11-07 | Buy | 454,545 | $11.00 | 4,999,995 |
|
Lexeo Therapeutics Inc LXEO
Common Stock
|
2023-11-07 | Conversion | 319,126 | ||
|
Vera Therapeutics Inc VERA
Class A Common Stock
|
2023-02-06 | Buy | 1,714,285 | $7.00 | 11,999,995 |
|
Vera Therapeutics Inc VERA
Class A Common Stock
|
2022-02-10 | Buy | 333,333 | $15.00 | 4,999,995 |
|
Vera Therapeutics Inc VERA
Class A Common Stock
|
2021-05-18 | Conversion | 2,187,504 | ||
|
Vera Therapeutics Inc VERA
Class A Common Stock
|
2021-05-18 | Buy | 909,090 | $11.00 | 9,999,990 |
|
Vera Therapeutics Inc VERA
Series C Preferred Stock · derivative
|
2021-05-18 | Conversion | 2,187,504 | $0.00 | |
|
Eargo Inc EAR
Common Stock
|
2021-04-14 | Other | 5,012 | $0.00 | |
|
Eargo Inc EAR
Common Stock
|
2021-04-14 | Other | 1,000,000 | $0.00 | |
|
Eargo Inc EAR
Common Stock
|
2020-10-20 | Buy | 233,333 | $18.00 | 4,199,994 |
|
Eargo Inc EAR
Series E Preferred Stock · derivative
|
2020-10-20 | Conversion | 3,685,358 | $0.00 | |
|
Eargo Inc EAR
Common Stock
|
2020-10-20 | Conversion | 3,685,358 |